Rat Cardiomyocytes

Cat.No.: CSC-C1151Z

Species: Rat

Source: Heart

Cell Type: Cardiomyocyte

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C1151Z
Description
Rat Cardiomyocytes are high quality primary myocyte cells prepared by standardized methods, and are ready for immediate culture upon thaw. Each lot of these cells test positive for functional syncytium formation, and stain positive for actinin. Cells also test negative for mycoplasma and bacteria. Primary cardiac myocyte cells need an appropriate substrate to adhere and survive. The preferred substrate is nitrocellulose.
Species
Rat
Source
Heart
Application
For Research Use Only
Cell Type
Cardiomyocyte
Disease
Normal
Storage
LN2
Shipping
Dry Ice
Quality Control
Sterility Tests: Negative for bacteria, fungi, and yeast.
Storage and Shipping
Frozen cells are shipped on dry ice.
Upon receipt, if no dry ice is left in the package, thaw and use cells immediately.
If there is dry ice left in the package, store it in liquid nitrogen immediately upon arrival.
When stored at the recommended storag
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Rat cardiomyocytes are terminally differentiated, specialized muscle cells isolated from rat heart tissue. Two principal preparations are utilized in research: neonatal rat cardiomyocytes (NRCMs) , isolated from 1-2 day-old pups, and adult rat ventricular myocytes (ARVMs), harvested from mature animals. NRCMs exhibit a characteristic elongated, striated morphology and display spontaneous, rhythmic contractions in culture, while ARVMs retain a rod-shaped morphology with organized sarcomeres and functional excitation-contraction coupling.

A key advantage of rat cardiomyocytes is their high physiological relevance. Isolated cells closely resemble the intact myocardium in many respects, preserving critical in vivo features such as sarcomeric alignment, ion channel expression, and calcium-handling properties. This makes them superior to immortalized cell lines for studying fundamental cardiac biology. Neonatal cells are particularly advantageous due to their relative ease of isolation, robust spontaneous beating, and high viability in culture. They express well-defined electrophysiological properties including L- and T-type calcium currents and distinct action potentials. Adult cells, while more technically challenging to isolate and maintain, provide a model that more faithfully represents mature myocardial function.

Rat cardiomyocytes serve as an invaluable platform for investigating cardiac development, hypertrophy, ischemia-reperfusion injury, and drug-induced cardiotoxicity. They are amenable to live-cell imaging, electrophysiological recording, and genetic manipulation via viral transduction. Despite inherent limitations-including species-specific differences in electrophysiology compared to humans and the post-mitotic nature of adult cells-rat cardiomyocytes remain a gold-standard ex vivo model bridging fundamental cardiovascular biology and preclinical drug discovery.

Faecalibacterium Prausnitzii Prevents Age-Related Heart Failure by Suppressing Ferroptosis in Cardiomyocytes

Aging is a primary driver of the escalating prevalence of heart failure (HF). Age-associated gut microbiota dysbiosis has been implicated in various age-related diseases, yet its role in age-related HF remains largely unexplored. In this study, we sought to explore the potential link between age-related gut microbiota alterations and HF in the elderly.

We analyzed a publicly available single-cell sequencing dataset, which revealed markedly increased ferroptosis activity in cardiac myocytes of elderly individuals compared to their younger counterparts. Notably, treatment with the ferroptosis inhibitor, ferrostatin-1, mitigated cardiac ferroptosis and prevented cardiac dysfunction in aging rats. Furthermore, fecal microbiota transplantation from elderly HF patients significantly increased cardiac ferroptosis activity and induced cardiac dysfunction in healthy recipient rats. Integrated 16S rRNA sequencing and PCR quantification revealed a marked depletion of Faecalibacterium prausnitzii (F. prausnitzii) in elderly individuals, with a more pronounced decline in elderly patients with HF. Oral administration of F. prausnitzii or its metabolite butyrate effectively attenuated age-related HF through inhibiting ferroptosis. Additionally, gene-editing techniques were employed to generate F. prausnitzii BCoAT mutant deficient in butyrate production. Intriguingly, the protective effect was lost in the butyrate-deficient F. prausnitzii strain.

These findings highlight the critical role of aged microbiota-induced ferroptosis in HF and propose F. prausnitzii or butyrate may serve as potential targets for the prevention and treatment of age-related HF.

Oral supplementation of F. prausnitzii prevents rats from age-related heart failure.

Fig. 1. F. prausnitzii inhibits cardiac ferroptosis and prevents the development of age-related heart failure (Zhang, Yun, et al., 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products